AstraZeneca and Siam Bioscience announced on Wednesday that they are ready to start supplying the government with COVID-19 vaccine produced in Thailand. The first locally produced doses will be supplied to the Thai Public Health Ministry, to support their mass vaccination program.
AstraZeneca (Thailand) president James Teague said ramping up the production of vaccine in Thailand in only a few months is a tremendous achievement, which is due to outstanding collaboration with the company’s manufacturing partner, Siam Bioscience.
He said, now that AstraZeneca is ready to deliver a high-quality vaccine, the company can help the Thai government achieve its goal of ensuring the effective vaccination of people in the country as quickly as possible.
Meanwhile, the Department of Disease Control said the first lot of 240,000 AstraZeneca doses will be sent to 58 provinces, with around 3,600 doses for each province by June 2. The next lot of 350,000 doses will be sent to the other 19 provinces in the next two weeks, while another 200,000 doses of the Sinovac vaccine will also be distributed to vaccination units nationwide in June.
AstraZeneca (Thailand) president James Teague said ramping up the production of vaccine in Thailand in only a few months is a tremendous achievement, which is due to outstanding collaboration with the company’s manufacturing partner, Siam Bioscience.
He said, now that AstraZeneca is ready to deliver a high-quality vaccine, the company can help the Thai government achieve its goal of ensuring the effective vaccination of people in the country as quickly as possible.
Meanwhile, the Department of Disease Control said the first lot of 240,000 AstraZeneca doses will be sent to 58 provinces, with around 3,600 doses for each province by June 2. The next lot of 350,000 doses will be sent to the other 19 provinces in the next two weeks, while another 200,000 doses of the Sinovac vaccine will also be distributed to vaccination units nationwide in June.
